Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 21/02/2012
PIL Fosamax Once Weekly 70mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/02/2012 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 25/10/2011 and displayed until 21/02/2012
Reasons for adding or updating:
  • Change to packaging
  • Change to drug interactions
Updated on 21/09/2011 and displayed until 25/10/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 02/06/2011 and displayed until 21/09/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 03/02/2011 and displayed until 02/06/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 13/04/2010 and displayed until 03/02/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 26/11/2009 and displayed until 13/04/2010
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about driving or using machinery
  • Change to dosage and administration
Updated on 21/07/2009 and displayed until 26/11/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 27/05/2008 and displayed until 21/07/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 31/08/2007 and displayed until 27/05/2008
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
  • Change to side-effects
Updated on 28/08/2007 and displayed until 31/08/2007
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 02/01/2007 and displayed until 28/08/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 10/11/2006 and displayed until 02/01/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 15/06/2004 and displayed until 10/11/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 25/07/2002 and displayed until 15/06/2004
Reasons for adding or updating:
  • New PIL for new product
Updated on 18/07/2001 and displayed until 25/07/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 02/01/2001 and displayed until 18/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  alendronate sodium trihydrate